https://www.zonebourse.com/cours/action/ADDEX-THERAPEUTICS-LTD-261774/actualite/Addex-demarre-la-phase-II-pour-un-traitement-contre-l-epilepsie-32242114/?utm_source=telegram&utm_medium=social&utm_campaign=share